Variable | No Adverse Event (n = 382) | Reported (n = 20) | Confirmed (n = 15) | All participants (n = 417) |
---|---|---|---|---|
Age (IQR) | 68 (57, 75) | 61 (57, 75) | 67 (50, 75) | 67 (57, 75) |
Female sex (%) | 213 (56%) | 12 (60%) | 8 (53%) | 234 (56%) |
BMI (IQR) | 28 (25, 31) | 33 (29, 36) | 30 (26, 35) | 28 (25, 32) |
Retired (%) | 222 (60%) | 17 (55%) | 7 (50%) | 240 (59%) |
WPAI (IQR) | 70 (50, 80) | 70 (70, 90) | 65 (40, 80) | 70 (50, 80) |
EQ5D (IQR) | 0.52 (0.06, 0.70) | 0.52 (0.6, 0.62) | 0.16 (0.02, 0.69) | 0.52 (0.6, 0.69) |
WOMAC (IQR) | 59.9 (50, 69.8) | 60.1 (54.2, 77.1) | 59.4 (55.2, 70.8) | 59 (50, 70) |